Published in Nature on June 15, 1995
Population genetics of BRCA1 and BRCA2. Am J Hum Genet (1997) 3.28
Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet (2004) 2.40
BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Natl Acad Sci U S A (1997) 2.02
Tumorigenesis in mice carrying a truncating Brca1 mutation. Genes Dev (2001) 1.94
Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet (1995) 1.85
CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc Natl Acad Sci U S A (2000) 1.41
Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer. Cancer Discov (2012) 1.25
Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites. J Med Genet (1996) 0.96
BRCA1 and BRCA2 proteins: roles in health and disease. Mol Pathol (1998) 0.94
Evidence of a founder BRCA1 mutation in Scotland. Br J Cancer (2000) 0.83
When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans. Hered Cancer Clin Pract (2016) 0.77
Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testing. Hered Cancer Clin Pract (2009) 0.76
Breast cancer 1 (BRCA1)-deficient embryos develop normally but are more susceptible to ethanol-initiated DNA damage and embryopathies. Redox Biol (2015) 0.75
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA (1999) 11.23
Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet (1993) 9.34
Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA (1990) 6.25
An influenza simulation model for immunization studies. Am J Epidemiol (1976) 4.12
Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab (2001) 4.03
Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet (1992) 3.89
Application of operant conditioning procedures to the behavior problems of an autistic child: a follow-up and extension. Behav Res Ther (1967) 3.23
The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med (1998) 3.13
Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1992) 2.82
Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc (2000) 2.80
Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med (1993) 2.65
Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med (1997) 2.50
The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism. J Virol (1992) 2.49
Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med (1989) 2.43
Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA (1992) 2.42
THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. Am J Hum Genet (1993) 2.37
The accuracy of self-report of fractures in elderly women: evidence from a prospective study. Am J Epidemiol (1992) 2.33
Head injuries in skiers and snowboarders in British Columbia. Can J Neurol Sci (2001) 2.19
Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (1984) 2.14
19-year incidence of neural tube defects in area under constant surveillance. Lancet (1981) 2.13
Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation (2001) 2.12
Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol (1996) 2.09
The hospitalist: a third alternative. Med J Aust (2000) 2.02
Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med (1998) 1.96
Family and personal networks in international migration: recent developments and new agendas. Int Migr Rev (1989) 1.89
Evaluation of the rapid CLEARVIEW Chlamydia test for direct detection of chlamydiae from cervical specimens. J Clin Microbiol (1991) 1.80
Changes in needle sharing behavior among intravenous drug users: San Francisco, 1986-88. Am J Public Health (1990) 1.80
Prevalence and natural history of primary speech and language delay: findings from a systematic review of the literature. Int J Lang Commun Disord (2000) 1.79
Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res (1995) 1.77
Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function. Oncogene (2006) 1.73
Age-related decrements in bone mineral density in women over 65. J Bone Miner Res (1992) 1.69
Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child (1991) 1.65
Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet (2000) 1.62
Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens (1992) 1.60
Bone mineral density predicts non-spine fractures in very elderly women. Study of Osteoporotic Fractures Research Group. Osteoporos Int (1994) 1.60
Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab (2010) 1.60
Postmarketing surveillance. BMJ (1994) 1.59
Screening for speech and language delay: a systematic review of the literature. Health Technol Assess (1998) 1.58
Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia. Atherosclerosis (2000) 1.58
Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams. J Clin Endocrinol Metab (2013) 1.57
Kyphosis in older women and its relation to back pain, disability and osteopenia: the study of osteoporotic fractures. Osteoporos Int (1994) 1.52
Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). Am J Med (2001) 1.51
Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol (1990) 1.49
Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group. Arch Intern Med (2000) 1.47
Nephritis in two children after irradiation and chemotherapy for nephroblastoma. Lancet (1974) 1.47
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients. Am J Cardiol (2000) 1.45
The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. Oncogene (2001) 1.45
Epidemiology of facial clefting. Arch Dis Child (1985) 1.43
Amplification of KP elements associated with the repression of hybrid dysgenesis in Drosophila melanogaster. Genetics (1988) 1.41
Damaging diagnosis of myalgic encephalitis in children. BMJ (1989) 1.41
Correlates of kyphosis in older women. The Fracture Intervention Trial Research Group. J Am Geriatr Soc (1997) 1.40
Updated fracture incidence rates for the US version of FRAX. Osteoporos Int (2009) 1.40
Health effects of gasoline exposure. II. Mortality patterns of distribution workers in the United States. Environ Health Perspect (1993) 1.39
Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin. J Am Coll Cardiol (1998) 1.36
Etiologic determinants of abruptio placentae. Obstet Gynecol (1997) 1.35
The NM23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with BglII. Genes Chromosomes Cancer (1992) 1.34
Digital X-ray radiogrammetry predicts hip, wrist and vertebral fracture risk in elderly women: a prospective analysis from the study of osteoporotic fractures. Osteoporos Int (2002) 1.32
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol (1995) 1.31
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA (1996) 1.29
Hypothyroidism due to auto-immune thyroiditis in a young child with Down's syndrome. Arch Dis Child (1967) 1.28
Degenerative change in symptomatic scaphoid nonunion. J Hand Surg Am (1987) 1.28
Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1. Hum Mol Genet (1993) 1.27
Reported awareness of tobacco advertising and promotion in China compared to Thailand, Australia and the USA. Tob Control (2009) 1.26
Effect of a lifestyle intervention on bone mineral density in premenopausal women: a randomized trial. Am J Clin Nutr (1999) 1.22
Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1998) 1.22
Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis. J Clin Endocrinol Metab (2006) 1.21
Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions. Osteoporos Int (2001) 1.18
Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. Systolic Hypertension in the Elderly Program. J Gerontol (1987) 1.18
A generalized equation for prediction of VO2peak from 1-mile run/walk performance. Med Sci Sports Exerc (1995) 1.17
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene (1998) 1.16
Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene (1999) 1.16
The prenatal exclusion test for Huntington's disease: experience in the west of Scotland, 1986-1993. J Med Genet (1995) 1.16
In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrob Agents Chemother (1994) 1.14
Gout with Hyperparathyroidism: Report of Case with Examination of Synovial Fluid. Br Med J (1965) 1.13
The incidence of Down's syndrome over a 19-year period with special reference to maternal age. J Med Genet (1983) 1.12
Retroviral transduction of T-cell antigen receptor beta-chain and myc genes. Nature (1987) 1.11
Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils. Eur J Pharmacol (1996) 1.11
Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int J Cancer (1993) 1.10
HTLV-I among Northern Territory blood donors. Med J Aust (1993) 1.09
Problems with overdoses of sustained-release aspirin. Lancet (1981) 1.09
The intergenic region of maize streak virus contains promoter elements involved in rightward transcription of the viral genome. EMBO J (1988) 1.08
Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region. Int J Cancer (1993) 1.07
STANDARDIZATION OF PUBLIC HEALTH TRAINING: Report of the Committee of Sixteen. Am J Public Health (N Y) (1921) 1.06
Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. J Bone Miner Res (1999) 1.05
The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension (1993) 1.05
Hearing conservation. J R Soc Med (1978) 1.05
Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J Natl Cancer Inst (1995) 1.05
Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner. Atherosclerosis (2001) 1.05
Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinases. J Med Chem (1995) 1.04
Regulation of BRCA1. Nature (1995) 1.04
Conservation of the c-myc coding sequence in transduced feline v-myc genes. Virology (1986) 1.03
A comparison of related and unrelated marrow donors. Psychosom Med (1998) 1.03